Pharmacyclics Inc (NASDAQ:PCYC)

256.59
Delayed Data
As of Apr 24
 -0.51 / -0.20%
Today’s Change
82.51
Today|||52-Week Range
260.47
+109.87%
Year-to-Date

Stock Price Forecast

The 17 analysts offering 12-month price forecasts for Pharmacyclics Inc have a median target of 261.00, with a high estimate of 261.25 and a low estimate of 184.00. The median estimate represents a +1.72% increase from the last price of 256.59.

Analyst Recommendations

The current consensus among 19 polled investment analysts is to Hold stock in Pharmacyclics Inc. This rating has held steady since April, when it was unchanged from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.14
Sales
$226.8M
Reporting Date
May 01

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -82.99%
 
 
 
 
 
 
Growthannually -48.98%
 
 
 
 
 
 

Sales

Growthquarterly -21.85%
 
 
 
 
 
 
Growthannually 51.84%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account